Immune Pharmaceuticals Inc (fka IMNPQ)

[Investor100]

Management Invest's @ IMNP

As the saying goes "put your money where your mouth is" was proven back in August with a substancial personal investment into IMNP stock.

August 5th, 2016

http://finance.yahoo.com/news/immune-pharmaceuticals-inc-imnp-ceo-061503523.html;_ylt=AwrBT8FWV0tYDXwA2E1XNyoA;_ylu=X3oDMTEyaGJwcmJrBGNvbG8DYmYxBHBvcwM0BHZ0aWQDQjI5MTNfMQRzZWMDc3I-

Immune Pharmaceuticals Inc (IMNP) CEO Daniel Gedeon Teper Bought $356,250 of Stocks

CEO of Immune Pharmaceuticals Inc (IMNP) Daniel Gedeon Teper bought 937,500 shares of IMNP on 08/04/2016 at an average price of $0.38 a share. The total cost of this purchase was $356,250.

Immune Pharmaceuticals Inc is a clinical stage biopharmaceutical company specializing in the development and commercialization of targeted therapeutics for the treatment of inflammatory diseases and cancer. Immune Pharmaceuticals Inc has a market cap of $13.513 million; its shares were traded at around $0.33 .

CEO Recent Trades:

CEO, 10% Owner Daniel Gedeon Teper bought 937,500 shares of IMNP stock on 08/04/2016 at the average price of $0.38.

Directors and Officers Recent Trades:

EVP & CMO Monica E. Luchi bought 777,778 shares of IMNP stock on 08/04/2016 at the average price of $0.45.

Director Daniel Kazado bought 666,667 shares of IMNP stock on 08/04/2016 at the average price of $0.45.


For a complete lists of insider holdings:
http://openinsider.com/search?q=imnp